Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis

New England Journal of Medicine

Volumn 343, Issue 13, 2000, Pages 898-904

  Jacobs, Lawrence D ^a,g   Beck, Roy W ^b   Simon, Jack H ^c   Kinkel, R Phillip ^d   Brownscheidle, Carol M ^a   Murray, Thomas J ^e   Simonian, Nancy A ^f   Slasor, Peter J ^f   Sandrock, Alfred W ^f  

^a UNIVERSITY AT BUFFALO   (United States)

^b JAEB CENTER FOR HEALTH RESEARCH   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^f BIOGEN   (United States)

^g BUFFALO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMYELINATING DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTIBODIES; BRAIN; CEREBELLAR DISEASES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELITIS, TRANSVERSE; OPTIC NEURITIS; PROBABILITY;

EID: 0034727059     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200009283431301     Document Type: Article

References (17)

1. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
2. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis
3. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions: A quantitative study
4. The 5-year risk of MS after optic neuritis: Experience of the Optic Neuritis Treatment Trial
5. Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis
6. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis: A 5-year follow-up study
7. The prognostic value of brain MRI in clinically isolated syndromes of the CNS: A 10-year follow-up
8. Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination
9. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis
10. Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
11. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
12. Magnetic resonance studies of intramuscular interferon β-1a for relapsing multiple sclerosis
13. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS
14. Minimization: A new method of assigning patients to treatment and control groups
15. Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis
16. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS)
17. The clinical profile of optic neuritis: Experience of the Optic Neuritis Treatment Trial